A case of Staphylococcus aureus enterocolitis: A rare entity

Gastroenterology and Hepatology

Volumn 6, Issue 2, 2010, Pages 117-119

  Kotler, Donald P ^a   Sordillo, Emilia Mia ^a,b  

^a ST LUKE S ROOSEVELT HOSPITAL CENTER   (United States)

^b Columbia University College of Physicians and Surgeons ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CLINDAMYCIN; LINCOMYCIN; METRONIDAZOLE; PROTON PUMP INHIBITOR; QUINOLINE DERIVED ANTIINFECTIVE AGENT; STAPHYLOCOCCUS ENTEROTOXIN; VANCOMYCIN;

ABDOMINAL SURGERY; AGE DISTRIBUTION; ANTIBIOTIC THERAPY; ARTICLE; CLOSTRIDIUM DIFFICILE; ENTEROCOLITIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOCOMPROMISED PATIENT; IMMUNOSUPPRESSIVE TREATMENT; NONHUMAN; PATHOGENESIS; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION;

EID: 77950534156     PISSN: 15547914     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Felsen J, Wolarsky W. Epidemic diarrhea of the newborn. Arch Pediatr. 1942;59:495-512.
2. Cunha BA. Nosocomial diarrhea. Crit Care Clin. 1998;14:329-338.
3. Thakkar S, Agrawal R. A case of Staphylococcus aureus enterocolitis: a rare entity. Gastroenterol Hepatol. 2010;6:115-117.
4. Boyce JM, Havill NL. Nosocomial antibiotic-associated diarrhea associated with enterotoxin-producing strains of methicillin-resistant Staphylococcus aureus. Am J Gastroenterol. 2005;100:1828-1834.
5. Asha NJ, Tompkins D, Wilcox MH. Comparative analysis of prevalence, risk factors, and molecular epidemiology of antibiotic-associated diarrhea due to Clostridium difficile, Clostridium perfringens, and Staphylococcus aureus. J Clin Microbiol. 2006;44:2785-2791.
6. Rhee KY, Soave R, Maltz C. Methicillin-resistant Staphylococcus aureus as a cause of antibiotic-associated diarrhea. J Clin Gastroenterol. 2004;38:299-300.
7. Gruber WC, Pietsch JB. Toxic shock syndrome associated with Staphylococcus aureus enterocolitis. Pediatr Infect Dis J. 1988;7:71-79.
8. Kotler DP, Sandkovsky U, Schlievert PM, Sordillo EM. Toxic shock-like syndrome associated with staphylococcal enterocolitis in an HIV-infected man. Clin Infect Dis. 2007;44:e121-123.
9. McCormick JK, Yarwood JM, Schlievert PM. Toxic shock syndrome and bacterial superantigens: an update. Ann Rev Microbiol. 2001;55:77-104.
10. Lindsay JA, Ruzin A, Ross HF, Kurepina N, Novick RP. The gene for toxic shock toxin is carried by a family of mobile pathogenicity islands in Staphylococcus aureus. Mol Microbiol. 1998;29:527-543.
11. Yarwood JM, Schlievert PM. Quorum sensing in Staphylococcus infections. J Clin Invest. 2003;112:1620-1625.
12. Hamad AR, Marrack P, Kappler JW. Transcytosis of staphylococcal superantigen toxins. J Exp Med. 1997;185:1447-1454.
13. Li H, Llera A, Malchiodi EL, Mariuzza RA. The structural basis of T cell activation by superantigens. Annu Rev Immunol. 1999;17:435-466.
14. Benjamin MA, Lu J, Donnelly G, Dureja P, McKay DM. Changes in murine jejunal morphology evoked by the bacterial superantigen Staphylococcus aureus enterotoxin B are mediated by CD4+ T cells. Infect Immun. 1998;66:2193-2199.
15. McKay DM, Benjamin MA, Lu J. CD4+ T cells mediate superantigen-induced abnormalities in murine jejunal ion transport. Am J Physiol. 1998;275:G29-38.
16. Stiles BG, Garza AR, Ulrich RG, Boles JW. Mucosal vaccination with recombinantly attenuated staphylococcal enterotoxin B and protection in a murine model. Infect Immun. 2001;69:2031-2036.
17. Stone SP, Beric V, Quick A, Balestrini AA, Kibbler CC. The effect of an enhanced infection-control policy on the incidence of Clostridium difficile infection and methicillin-resistant Staphylococcus aureus colonization in acute elderly medical patients. Age Ageing. 1998;27:561-568.
18. Henderson DK. Managing methicillin-resistant staphylococci: a paradigm for preventing nosocomial transmission of resistant organisms. Am J Infect Control. 2006;34:S46-54.